{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:47:56Z","timestamp":1791960476039,"version":"4.3.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10067-013-2315-2","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T08:50:49Z","timestamp":1372927849000},"page":"1673-1675","source":"Crossref","is-referenced-by-count":25,"title":["Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"Clara","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Mart\u00edn-Begu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"2315_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","volume":"12","author":"K Sabri","year":"2008","unstructured":"Sabri K, Saurenmann RK, Silverman ED et al (2008) Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 12:539\u2013545","journal-title":"J AAPOS"},{"key":"2315_CR2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","volume":"104","author":"MR Dana","year":"1997","unstructured":"Dana MR, Merayo-Lloves J, Schaumberg DA et al (1997) Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 104:236\u2013244","journal-title":"Ophthalmology"},{"key":"2315_CR3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","volume":"352","author":"E Silverman","year":"2005","unstructured":"Silverman E, Mouy R, Spiegel L et al (2005) Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med 352:1655\u20131666","journal-title":"N Engl J Med"},{"key":"2315_CR4","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"2315_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"2315_CR6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2165\/00003495-199958060-00010","volume":"58","author":"A Prakash","year":"1999","unstructured":"Prakash A, Jarvis B (1999) Leflunomide: a review of its use in active rheumatoid arthritis. Drugs 58:1137\u20131164","journal-title":"Drugs"},{"key":"2315_CR7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ophtha.2008.03.027","volume":"115","author":"JG Parikh","year":"2008","unstructured":"Parikh JG, Tawansy KA, Rao NA (2008) Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis. Ophthalmology 115:1833\u20131836","journal-title":"Ophthalmology"},{"key":"2315_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01983486","volume":"42","author":"SM Robertson","year":"1994","unstructured":"Robertson SM, Lang LS (1994) Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats. Agents Actions 42:167\u2013172","journal-title":"Agents Actions"},{"key":"2315_CR9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","volume":"9","author":"G Simonini","year":"2010","unstructured":"Simonini G, Cantarini L, Bresci C et al (2010) Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev 9:674\u2013683","journal-title":"Autoimmun Rev"},{"key":"2315_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09273940590951061","volume":"13","author":"EN Yu","year":"2005","unstructured":"Yu EN, Meniconi ME, Tufail F et al (2005) Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm 13:353\u2013360","journal-title":"Ocul Immunol Inflamm"},{"key":"2315_CR11","first-page":"362","volume":"32","author":"I Foeldvari","year":"2005","unstructured":"Foeldvari I, Wierk A (2005) Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32:362\u2013365","journal-title":"J Rheumatol"},{"key":"2315_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C et al (2007) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophtalmol 17:743\u2013748","journal-title":"Eur J Ophtalmol"},{"key":"2315_CR13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","volume":"23","author":"C Tappeiner","year":"2009","unstructured":"Tappeiner C, Roesel M, Heinz C et al (2009) Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye (Lond) 23:1192\u20131198","journal-title":"Eye (Lond)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2315-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2315-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T03:32:43Z","timestamp":1563334363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2315-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2315"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2315-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}